AbbVie Non-cash litigation reserve adjustments decreased by 1419.0% to -$319.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 201.6%, from $314.00M to -$319.00M. Over 3 years (FY 2021 to FY 2024), Non-cash litigation reserve adjustments shows an upward trend with a 46.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Frequent large adjustments may signal ongoing legal instability or uncertainty regarding potential liabilities.
This metric captures the net impact of non-cash adjustments to legal reserves, accounting for both the creation of new r...
Used by large-cap companies in litigious industries to manage and report legal exposure.
cf_abbv_litigation_reserve_adjustments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.75M | $40.75M | $40.75M | $560.75M | $560.75M | $560.75M | $560.75M | -$110.75M | -$110.75M | -$110.75M | -$110.75M | -$12.00M | $39.00M | $314.00M | $167.00M | -$729.00M | -$21.00M | -$319.00M |
| QoQ Change | — | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -119.8% | +0.0% | +0.0% | +0.0% | +89.2% | +425.0% | +705.1% | -46.8% | -536.5% | +97.1% | <-999% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -119.8% | -119.8% | -119.8% | -119.8% | +89.2% | +135.2% | +383.5% | +250.8% | <-999% | -153.8% | -201.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.